Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Imago BioSciences stock
Learn how to easily invest in Imago BioSciences stock.
Imago Biosciences Inc is a biotechnology business based in the US. Imago BioSciences shares (IMGO) are listed on the NASDAQ and all prices are listed in US Dollars. Imago BioSciences employs 40 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Imago BioSciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IMGO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Imago BioSciences stock price (NASDAQ: IMGO)Use our graph to track the performance of IMGO stocks over time.
Imago BioSciences shares at a glance
|Latest market close||$14.77|
|52-week range||$11.56 - $30.21|
|50-day moving average||$16.52|
|200-day moving average||$18.06|
|Wall St. target price||$35.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.16|
Buy Imago BioSciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Imago BioSciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Imago BioSciences price performance over time
|1 week (2022-09-16)||-9.94%|
|1 month (2022-08-24)||-12.19%|
|3 months (2022-06-24)||13.53%|
|6 months (2022-03-24)||-22.75%|
|1 year (2021-09-24)||-24.49%|
|2 years (2020-09-20)||N/A|
|3 years (2019-09-20)||N/A|
|5 years (2017-09-20)||N/A|
Imago BioSciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-25.36%|
|Return on equity TTM||-42.48%|
|Market capitalisation||$555 million|
TTM: trailing 12 months
Imago BioSciences share dividends
We're not expecting Imago BioSciences to pay a dividend over the next 12 months.
Imago BioSciences overview
Imago BioSciences, Inc. , a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California. .
Imago BioSciences in the news
Imago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of Imago BioSciences is owned by insiders or institutions?
Currently 3.545% of Imago BioSciences shares are held by insiders and 93.586% by institutions. How many people work for Imago BioSciences?
Latest data suggests 40 work at Imago BioSciences. When does the fiscal year end for Imago BioSciences?
Imago BioSciences's fiscal year ends in December. Where is Imago BioSciences based?
Imago BioSciences's address is: 329 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Imago BioSciences's ISIN number?
Imago BioSciences's international securities identification number is: US45250K1079
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert